A team of scientists from Oak Ridge National Laboratory, Cleveland Clinic and IBM has calculated nine molecular ...
Zed Industries, the Boulder, Colorado-based developer of the GPU-accelerated code editor Zed, on Thursday opened an early-access waitlist for DeltaDB, a new version control system that stores software ...
A Las Vegas woman admitted Tuesday that she killed her model friend during a photo shoot last year. Allysandra Blea, 20, pleaded guilty to a count of first-degree kidnapping and a count of involuntary ...
Led by Accenture Ventures with participation from Adobe Ventures, WndrCo, Metis Strategy, SLW, NAVER Ventures, and Fin Capital, the round validates Netomi as a leading enterprise-grade agentic CX ...
aDepartment of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, China ...
Quantum computers could solve certain problems that would take traditional classical computers an impractically long time to solve. At the Japan Advanced Institute of Science and Technology (JAIST), ...
Introduction Extension for Community Healthcare Outcomes (Project ECHO©) is an innovative model for continuing professional development that uses videoconferencing technology to support and train ...
1 School of Atmospheric Sciences, Key Laboratory of Meteorological Disaster of the Ministry of Education, Nanjing University of Information Science and Technology, Nanjing, China. 2 Tanzania ...
FunASR is a speech recognition framework developed by the Speech Lab of DAMO Academy, which integrates industrial-level models in the fields of speech endpoint detection, speech recognition, ...
An unexpectedly strong solar storm rocked our planet on April 23, 2023, sparking auroras as far south as southern Texas in the U.S. and taking the world by surprise. Subscribe to our newsletter for ...
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study PD-1 immune checkpoint ...